Clinical trial
Corticosteroid Sparing Effect of Methotrexate in Patients With Sarcoid- Associated Uveitis: A Double Blind, Randomized, Placebo Controlled-study -UVEXATE
NCT00918554 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Corticosteroid Sparing Effect of Methotrexate in Patients With Sarcoid- Associated Uveitis: A Double Blind, Randomized, Placebo Controlled-study -UVEXATE
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- September 30, 2009
- Completion date
- August 31, 2010
- Enrollment
- 7 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
macular edema, ocular sarcoidosis, sarcoid-associated uveitis